Literature DB >> 30374540

[85-year-old male with cutaneous blisters : Preparation for the medical specialist examination: Part 25].

Mareike Witte1, Enno Schmidt2, Ralf Ludwig2.   

Abstract

Mesh：

Year:  2018        PMID： 30374540     DOI： 10.1007/s00105-018-4291-6

Source DB:  PubMed          Journal:  Hautarzt        ISSN： 0017-8470            Impact factor:   0.751


× No keyword cloud information.
  21 in total

Review 1.  The diagnosis and treatment of autoimmune blistering skin diseases.

Authors:  Enno Schmidt; Detlef Zillikens
Journal:  Dtsch Arztebl Int       Date:  2011-06-10       Impact factor: 5.594

Review 2.  Structural proteins of the dermal-epidermal junction targeted by autoantibodies in pemphigoid diseases.

Authors:  Stephanie Goletz; Detlef Zillikens; Enno Schmidt
Journal:  Exp Dermatol       Date:  2017-12       Impact factor: 3.960

3.  Serration pattern analysis for differentiating epidermolysis bullosa acquisita from other pemphigoid diseases.

Authors:  Joost M Meijer; Ingeborg Atefi; Gilles F H Diercks; Artem Vorobyev; Janny Zuiderveen; Hillegonda J Meijer; Hendri H Pas; Detlef Zillikens; Enno Schmidt; Marcel F Jonkman
Journal:  J Am Acad Dermatol       Date:  2017-11-16       Impact factor: 11.527

Review 4.  Pemphigoid diseases.

Authors:  Enno Schmidt; Detlef Zillikens
Journal:  Lancet       Date:  2012-12-11       Impact factor: 79.321

5.  Bullous disorders associated with anti-PD-1 and anti-PD-L1 therapy: A retrospective analysis evaluating the clinical and histopathologic features, frequency, and impact on cancer therapy.

Authors:  Jacob Siegel; Mariam Totonchy; William Damsky; Juliana Berk-Krauss; Frank Castiglione; Mario Sznol; Daniel P Petrylak; Neal Fischbach; Sarah B Goldberg; Roy H Decker; Angeliki M Stamatouli; Navid Hafez; Earl J Glusac; Mary M Tomayko; Jonathan S Leventhal
Journal:  J Am Acad Dermatol       Date:  2018-07-17       Impact factor: 11.527

6.  Adjuvant treatment of severe/refractory bullous pemphigoid with protein A immunoadsorption.

Authors:  Franziska Hübner; Michael Kasperkiewicz; Diana Knuth-Rehr; Iakov Shimanovich; Joachim Hübner; Sven Süfke; Philip Muck; Detlef Zillikens; Enno Schmidt
Journal:  J Dtsch Dermatol Ges       Date:  2018-09       Impact factor: 5.584

7.  U-serrated immunodeposition pattern differentiates type VII collagen targeting bullous diseases from other subepidermal bullous autoimmune diseases.

Authors:  R M Vodegel; M F Jonkman; H H Pas; M C J M de Jong
Journal:  Br J Dermatol       Date:  2004-07       Impact factor: 9.302

8.  Serological diagnosis of autoimmune bullous skin diseases: prospective comparison of the BIOCHIP mosaic-based indirect immunofluorescence technique with the conventional multi-step single test strategy.

Authors:  Nina van Beek; Kristin Rentzsch; Christian Probst; Lars Komorowski; Michael Kasperkiewicz; Kai Fechner; Inga M Bloecker; Detlef Zillikens; Winfried Stöcker; Enno Schmidt
Journal:  Orphanet J Rare Dis       Date:  2012-08-09       Impact factor: 4.123

Review 9.  The Growing Incidence of Bullous Pemphigoid: Overview and Potential Explanations.

Authors:  Khalaf Kridin; Ralf J Ludwig
Journal:  Front Med (Lausanne)       Date:  2018-08-20

Review 10.  Comorbidities and Treatment Strategies in Bullous Pemphigoid: An Appraisal of the Existing Litterature.

Authors:  Rikke Bech; Line Kibsgaard; Christian Vestergaard
Journal:  Front Med (Lausanne)       Date:  2018-09-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.